Top compounds associated with response to FXYD2


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.5
mRNA UNC0321 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.5
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.023 0.5
mRNA fluvastatin CTRPv2 pan-cancer AAC -0.024 0.5
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.023 0.5
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA PF-3758309 CTRPv2 pan-cancer AAC 0.029 0.5
mRNA tivozanib CTRPv2 pan-cancer AAC -0.024 0.5
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.025 0.5
Download CSV